← back to search

Edward Kim

Drexel University · US
Area of research
Molecular Biology · Pulmonary and Respiratory Medicine
Research interest
Research interests include RNA modifications and cancer, Melanoma and MAPK Pathways, Lung Cancer Treatments and Mutations, and Adrenal and Paraganglionic Tumors.
h-index
32
citations
3,819
works
92
NIH funding
primary concept
email

Recent publications

Proceedings of the 1st biannual bridging the gaps in lung cancer conference
The Oncologist 2024cited by 1position: lastdoi
Multiple Endocrine Tumors Associated with Germline <i>MAX</i> Mutations: Multiple Endocrine Neoplasia Type 5?
The Journal of Clinical Endocrinology & Metabolism 2020cited by 95position: middledoi
The current state of molecular testing in the treatment of patients with solid tumors, 2019
CA A Cancer Journal for Clinicians 2019cited by 260position: middledoi
MITF Expression Predicts Therapeutic Vulnerability to p300 Inhibition in Human Melanoma
Cancer Research 2019cited by 57position: firstdoi
Targeting the CoREST complex with dual histone deacetylase and demethylase inhibitors
Nature Communications 2018cited by 231position: middledoi
Bayesian approach to determining penetrance of pathogenic SDH variants
Journal of Medical Genetics 2018cited by 63position: middledoi
microRNA-7 as a tumor suppressor and novel therapeutic for adrenocortical carcinoma
Oncotarget 2015cited by 83position: middledoi
Epidemiology of fragile X syndrome: A systematic review and meta‐analysis
American Journal of Medical Genetics Part A 2014cited by 453position: middledoi
MicroRNA-484 is more highly expressed in serum of early breast cancer patients compared to healthy volunteers
BMC Cancer 2014cited by 81position: middledoi
Breast cancer-associated fibroblasts induce epithelial-to-mesenchymal transition in breast cancer cells
Endocrine Related Cancer 2012cited by 124position: middledoi
Genetic Variants in the PI3K/PTEN/AKT/mTOR Pathway Predict Head and Neck Cancer Patient Second Primary Tumor/Recurrence Risk and Response to Retinoid Chemoprevention
Clinical Cancer Research 2012cited by 53position: middledoi

Grants

Collaborative Research: EPIIC Combining Partnerships and Entrepreneurship for Emerging Technologies (ComPEET)
NSF2519931$400,0002025–2028PIRePORTER
CAREER: Sparse Associative Deep Learning using Neural Mimicry in Multimodal Machine Learning
NSF1954364$473,5772019–2025PIRePORTER
CAREER: Sparse Associative Deep Learning using Neural Mimicry in Multimodal Machine Learning
NSF1846023$98,6162019–2019PIRePORTER

Frequent collaborators

Anthony J. Gill · The University of Sydney4 papers (2012–2020)Bruce G. Robinson · The University of Sydney2 papers (2014–2015)Stan B. Sidhu · Royal North Shore Hospital2 papers (2014–2015)Patsy Soon · Bankstown Lidcombe Hospital2 papers (2014–2015)Emma L. Duncan · King's College London2 papers (2018–2020)Trisha Dwight · The University of Sydney2 papers (2018–2020)Roderick Clifton‐Bligh · The University of Sydney2 papers (2018–2020)Diana E. Benn · The University of Sydney2 papers (2012–2018)Catherine Luxford · Royal North Shore Hospital2 papers (2018–2020)Jing Zhao · Northwestern University2 papers (2014–2015)Ying Zhu · North China University of Science and Technology1 papers (2018–2018)Ying Zhu · Wuhan University1 papers (2014–2014)Robert C. Baxter · The University of Sydney1 papers (2012–2012)Fred R. Hirsch · Mount Sinai Health System1 papers (2024–2024)Margaret R. Spitz · Children's Cancer Center1 papers (2012–2012) · 1 papers (2015–2015)Anne Richardson · Department of Conservation1 papers (2018–2018)Waun Ki Hong · Yong In University1 papers (2012–2012)Gregory I. Hockings · University of Queensland1 papers (2020–2020)Julian Ip · Northern Sydney Local Health District1 papers (2015–2015)